CLINICAL_TRIALS
trial_result
· 2017-01-09
Clinical Trial Update: Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy. [Phase 2]
Summary
Phase 2 open-label pharmacokinetic and safety/efficacy study of adjunctive brivaracetam in children with epilepsy completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2017-01-09